S&P 500   4,525.77 (-1.12%)
DOW   34,392.47 (-0.71%)
QQQ   384.04 (-1.51%)
AAPL   163.39 (-0.23%)
MSFT   325.14 (-1.32%)
FB   306.14 (-1.37%)
GOOGL   2,836.83 (-0.79%)
AMZN   3,399.00 (-1.12%)
TSLA   1,041.81 (-3.95%)
NVDA   307.23 (-4.37%)
BABA   112.75 (-7.58%)
NIO   33.06 (-8.67%)
CGC   9.95 (-3.96%)
AMD   143.74 (-4.61%)
GE   92.94 (-2.40%)
MU   82.49 (-0.47%)
T   23.22 (+0.74%)
F   19.53 (-1.71%)
DIS   145.43 (-1.20%)
PFE   53.70 (+1.24%)
AMC   27.85 (-8.03%)
ACB   5.92 (-3.58%)
BA   197.57 (-2.38%)
S&P 500   4,525.77 (-1.12%)
DOW   34,392.47 (-0.71%)
QQQ   384.04 (-1.51%)
AAPL   163.39 (-0.23%)
MSFT   325.14 (-1.32%)
FB   306.14 (-1.37%)
GOOGL   2,836.83 (-0.79%)
AMZN   3,399.00 (-1.12%)
TSLA   1,041.81 (-3.95%)
NVDA   307.23 (-4.37%)
BABA   112.75 (-7.58%)
NIO   33.06 (-8.67%)
CGC   9.95 (-3.96%)
AMD   143.74 (-4.61%)
GE   92.94 (-2.40%)
MU   82.49 (-0.47%)
T   23.22 (+0.74%)
F   19.53 (-1.71%)
DIS   145.43 (-1.20%)
PFE   53.70 (+1.24%)
AMC   27.85 (-8.03%)
ACB   5.92 (-3.58%)
BA   197.57 (-2.38%)
S&P 500   4,525.77 (-1.12%)
DOW   34,392.47 (-0.71%)
QQQ   384.04 (-1.51%)
AAPL   163.39 (-0.23%)
MSFT   325.14 (-1.32%)
FB   306.14 (-1.37%)
GOOGL   2,836.83 (-0.79%)
AMZN   3,399.00 (-1.12%)
TSLA   1,041.81 (-3.95%)
NVDA   307.23 (-4.37%)
BABA   112.75 (-7.58%)
NIO   33.06 (-8.67%)
CGC   9.95 (-3.96%)
AMD   143.74 (-4.61%)
GE   92.94 (-2.40%)
MU   82.49 (-0.47%)
T   23.22 (+0.74%)
F   19.53 (-1.71%)
DIS   145.43 (-1.20%)
PFE   53.70 (+1.24%)
AMC   27.85 (-8.03%)
ACB   5.92 (-3.58%)
BA   197.57 (-2.38%)
S&P 500   4,525.77 (-1.12%)
DOW   34,392.47 (-0.71%)
QQQ   384.04 (-1.51%)
AAPL   163.39 (-0.23%)
MSFT   325.14 (-1.32%)
FB   306.14 (-1.37%)
GOOGL   2,836.83 (-0.79%)
AMZN   3,399.00 (-1.12%)
TSLA   1,041.81 (-3.95%)
NVDA   307.23 (-4.37%)
BABA   112.75 (-7.58%)
NIO   33.06 (-8.67%)
CGC   9.95 (-3.96%)
AMD   143.74 (-4.61%)
GE   92.94 (-2.40%)
MU   82.49 (-0.47%)
T   23.22 (+0.74%)
F   19.53 (-1.71%)
DIS   145.43 (-1.20%)
PFE   53.70 (+1.24%)
AMC   27.85 (-8.03%)
ACB   5.92 (-3.58%)
BA   197.57 (-2.38%)
NASDAQ:RGNX

REGENXBIO SEC Filings & 10K Form

$31.12
-0.52 (-1.64%)
(As of 12/3/2021 10:39 AM ET)
Add
Compare
Today's Range
$30.44
▼
$32.00
50-Day Range
$30.19
▼
$43.63
52-Week Range
$27.02
▼
$50.26
Volume
1,064 shs
Average Volume
408,496 shs
Market Capitalization
$1.33 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.97

REGENXBIO (NASDAQ:RGNX) SEC Filings

DateFilerForm TypeView
09/15/2021
3:15 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2021
5:37 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2021
3:24 PM		MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2021
3:20 PM		Bennett Jean (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2021
6:14 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2021
6:06 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2021
3:22 PM		REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:21 PM		REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:20 PM		KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:19 PM		Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:17 PM		Fox Allan M. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:15 PM		BESHAR LUKE M (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:13 PM		Abdun-Nabi Daniel (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2021
3:17 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
3:22 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2021
3:30 PM		REGENXBIO (Filer)
Form DEFA14A
04/19/2021
3:15 PM		REGENXBIO (Filer)
Form DEF 14A
02/16/2021
7:54 AM		REGENXBIO (Subject)
Form SC 13G/A
02/10/2021
3:26 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
3:21 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2021
3:19 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
3:19 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
12:15 PM		JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G
01/14/2021
5:55 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
5:53 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
3:48 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:29 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:28 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:27 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:25 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
3:20 PM		REGENXBIO (Filer)
Form 424B5
01/06/2021
3:34 PM		REGENXBIO (Filer)
Form 424B5
01/06/2021
7:56 AM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:55 AM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:54 AM		PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:53 AM		Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:52 AM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
7:49 AM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
3:23 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:18 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2020
3:17 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
3:34 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
3:20 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
3:20 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2020
3:19 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
3:13 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2020
6:14 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2020
3:37 PM		Fox Allan M. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:31 PM		Fox Allan M. (Filed by)
REGENXBIO (Subject)
Form SC 13D/A
08/06/2020
3:20 PM		REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
3:10 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
3:22 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:05 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2020
3:37 PM		REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:30 PM		BESHAR LUKE M (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:30 PM		Abdun-Nabi Daniel (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
3:20 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
3:16 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
3:40 PM		REGENXBIO (Filer)
Form DEFA14A
04/08/2020
3:26 PM		REGENXBIO (Filer)
Form DEF 14A
04/02/2020
3:22 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2020
3:16 PM		GIC Private Ltd (Filed by)
REGENXBIO (Subject)
Form SC 13G
02/26/2020
3:50 PM		REGENXBIO (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2020
3:45 PM		REGENXBIO (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2020
3:25 PM		Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G
02/14/2020
7:10 AM		REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/12/2020
3:27 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:24 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
3:22 PM		HAYDEN DONALD J JR (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
3:23 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
3:21 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
11:30 AM		BlackRock Inc. (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/21/2020
3:18 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
3:17 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
3:16 PM		HAYDEN DONALD J JR (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
3:18 PM		HAYDEN DONALD J JR (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:20 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
6:11 AM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
3:23 PM		Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
3:22 PM		PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
3:21 PM		REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
3:20 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:24 PM		REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:21 PM		REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:11 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
6:16 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
3:12 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
3:24 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:17 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:22 PM		REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:10 PM		REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
3:33 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2019
3:29 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:11 PM		Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2019
3:20 PM		Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:25 PM		Fox Allan M. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:24 PM		REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:23 PM		REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:22 PM		KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:19 PM		Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.